DNLI - Denali Therapeutics GAAP EPS of -$0.80 misses by $0.10 revenue of $35.14M beats by $5.26M
2023-05-08 17:13:08 ET
- Denali Therapeutics press release ( NASDAQ: DNLI ): Q1 GAAP EPS of -$0.80 misses by $0.10 .
- Revenue of $35.14M (-16.6% Y/Y) beats by $5.26M .
For further details see:
Denali Therapeutics GAAP EPS of -$0.80 misses by $0.10, revenue of $35.14M beats by $5.26M